scispace - formally typeset
H

Huaichao Luo

Researcher at University of Electronic Science and Technology of China

Publications -  36
Citations -  390

Huaichao Luo is an academic researcher from University of Electronic Science and Technology of China. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 19 publications receiving 216 citations.

Papers
More filters
Journal ArticleDOI

Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes

TL;DR: It is concluded that oxygen pressure in the tumor microenvironment orchestrates an anti- and pro-tumoral γδ T-cell equilibrium by altering TEX content, which subsequently regulates MDSC function in a miR-21/PTEN/PD-L1-axis-dependent manner.
Journal ArticleDOI

Normal Reference Intervals of Neutrophil-To-Lymphocyte Ratio, Platelet-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Systemic Immune Inflammation Index in Healthy Adults: a Large Multi-Center Study from Western China.

TL;DR: This study addresses possible variations and establishes consensus for the NLR, PLR, LMR, and SII RIs for healthy Han Chinese adults in western China and shows that established RIs can standardize clinical applications and promote the use of these indicators into the routine complete blood count report.
Journal ArticleDOI

γδTDEs: An Efficient Delivery System for miR-138 with Anti-tumoral and Immunostimulatory Roles on Oral Squamous Cell Carcinoma.

TL;DR: It is concluded that γδTDEs delivering miR-138 could achieve synergetic therapeutic effects onOSCC, which is benefited from the individual direct anti-tumoral effects on OSCC and immunostimulatory effects on T cells.
Journal ArticleDOI

Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis

TL;DR: The metaanalysis result suggested that among HBV-carrying lymphoma patients undergoing chemotherapy, entecavir is more effective than lamivudine in preventing HBV reactivation.
Journal ArticleDOI

Dexamethasone Stimulates Hepatitis B Virus (HBV) Replication Through Autophagy.

TL;DR: It is found that dexamethasone stimulates HBV replication and protein expression by inducing autophagy in HepG2.2.15 cells and this might provide a novel insight into the mechanism of glucocorticoid-mediated HBV reactivation through autophagic, which might be a new therapeutic target.